GO:0070723 response to cholesterol: Cellular Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070723 (response to cholesterol) describes any process by which a cell or organism changes its state or activity in response to a cholesterol stimulus.
• Cholesterol is not only a membrane lipid but also a signaling molecule that modulates innate immunity, inflammation, and stress adaptation.
• Individual variation in serum cholesterol response to diet is well documented, with hypo- and hyperresponders showing distinct metabolic responses.
• Cholesterol biosynthesis and uptake are tightly linked to adaptive stress responses through SREBP and related pathways.
• Dysregulated cholesterol response contributes to cancer progression, treatment resistance, and cardiovascular disease risk.
• CRISPR-based models (KO, point mutation, knock-in, overexpression) enable causal dissection of genes mediating response to cholesterol.
Description
GO:0070723 (response to cholesterol) is a Gene Ontology biological process term that captures any change in a cell or organism's state or activity as a result of a cholesterol stimulus. This includes changes in gene expression, enzyme production, secretion, movement, and other cellular activities triggered by cholesterol or its derivatives. Cholesterol is a fundamental sterol that serves both as a structural component of membranes and as a precursor for steroid hormones, bile acids, and oxysterols, and its availability and distribution are sensed by multiple cellular systems. Understanding how cells respond to cholesterol is therefore central to lipid biology, immunology, and metabolic disease research. The response to cholesterol is not uniform across individuals or cell types. Human studies have identified hypo- and hyperresponders who differ in how serum cholesterol concentrations change in response to dietary cholesterol and saturated fat. These inter-individual differences have implications for cardiovascular disease risk and for interpreting nutritional studies. At the cellular level, cholesterol loading or depletion activates transcriptional programs, especially through sterol regulatory element-binding proteins (SREBPs), which coordinate de novo cholesterol synthesis and uptake with extracellular stress responses. In disease contexts, the response to cholesterol intersects with cancer biology and immunity. For example, cholesterol desensitizes endometrial cancer to progestin by attenuating progestin signaling, linking cholesterol response to endocrine therapy resistance. In colorectal cancer, radiotherapy-induced cholesterol biosynthesis inhibits cGAS-STING activation and contributes to treatment resistance. These findings position GO:0070723 as a clinically relevant process that can be studied with CRISPR models and functional genomics.
response to cholesterol At A Glance
| GO ID | GO:0070723 |
|---|---|
| GO term | response to cholesterol |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus. |
| Major function | Mediates cellular and organismal adaptation to cholesterol availability, including transcriptional, metabolic, and immune responses. |
| Related processes | Cholesterol biosynthesis, SREBP-mediated sterol sensing, innate immune signaling, and inflammatory responses. |
| Disease relevance | Cancer therapy resistance, cardiovascular disease risk, and individual variation in dietary cholesterol response. |
| Research methods | CRISPR KO/knock-in/overexpression, RNA-seq, proteomics, lipidomics, and functional assays. |
What Is GO:0070723?
According to the Gene Ontology, GO:0070723 (response to cholesterol) is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus. In other words, it is the collection of cellular and organismal reactions triggered when cholesterol is sensed, whether that leads to altered transcription, metabolic flux, immune signaling, or other functional outputs.
Why Is response to cholesterol Important in Cell Biology?
GO:0070723 is important because cholesterol is both a structural lipid and a signaling molecule, and the way cells respond to it influences immunity, inflammation, metabolism, and cancer treatment outcomes. Understanding this process helps explain why individuals differ in their serum cholesterol response to diet and why some tumors resist therapy through cholesterol-dependent mechanisms.
• Cholesterol is a key regulator of innate immunity and inflammation, making response to cholesterol central to host defense and inflammatory disease.
• SREBP-mediated cholesterol synthesis is part of the adaptive response to extracellular stress, linking lipid metabolism to cell survival.
• Individual variation in serum cholesterol response to dietary fat and cholesterol affects cardiovascular risk interpretation.
• Cholesterol desensitizes endometrial cancer to progestin by attenuating progestin signaling, highlighting a role in endocrine therapy resistance.
• Radiotherapy-induced cholesterol biosynthesis inhibits cGAS-STING activation and contributes to colorectal cancer treatment resistance.
• Dietary saturated fat and cholesterol responses remain a public health topic with ongoing controversy, requiring mechanistic clarity.
• CRISPR models allow causal testing of genes involved in cholesterol response, moving beyond correlative epidemiology.
• Response to cholesterol intersects with lipid rafts, membrane organization, and signal transduction, affecting many pathways.
• The process is relevant to drug discovery, as targeting cholesterol response pathways may sensitize tumors to therapy.
• Understanding hypo- and hyperresponder phenotypes can inform personalized nutrition and risk stratification.
What Happens During response to cholesterol?
Cholesterol sensing and SREBP activation
In simple terms: Cells monitor cholesterol levels and switch genes on or off to keep cholesterol in balance.
When cholesterol availability changes, cells activate sterol regulatory element-binding proteins (SREBPs) to adjust de novo cholesterol synthesis and uptake. This transcriptional response is part of a broader adaptive response to extracellular stress, allowing cells to maintain membrane integrity and metabolic homeostasis. The SREBP pathway is a canonical example of how a cholesterol stimulus is converted into changes in gene expression, a core feature of GO:0070723.
Inflammatory and innate immune signaling
In simple terms: Cholesterol can turn immune alarms on or off, shaping inflammation.
Cholesterol and its metabolites modulate innate immune signaling and inflammatory responses. Cholesterol crystals and altered cholesterol trafficking can activate inflammasomes and affect cytokine production, while cholesterol-lowering or loading conditions change immune cell states. This places response to cholesterol at the interface of lipid metabolism and immunity, with implications for atherosclerosis and other inflammatory diseases.
Cholesterol biosynthesis as a stress-adaptive response
In simple terms: Under stress, cells may ramp up cholesterol production to survive.
De novo cholesterol synthesis is at the crossroads of adaptive responses to extracellular stress through SREBP. Stress conditions can induce cholesterol biosynthetic genes, and this response can alter downstream signaling and therapy sensitivity. In colorectal cancer, radiotherapy induces cholesterol biosynthesis, which inhibits cGAS-STING activation and contributes to treatment resistance, illustrating how a stress-triggered cholesterol response can be maladaptive in disease.
Cholesterol response in cancer therapy resistance
In simple terms: Cholesterol changes can make tumors less responsive to treatment.
Cholesterol desensitizes endometrial cancer to progestin by attenuating progestin signaling, linking cholesterol response to endocrine therapy resistance. In colorectal cancer, cholesterol biosynthesis induced by radiotherapy suppresses cGAS-STING activation and contributes to resistance. These examples show that GO:0070723 is not only a homeostatic process but also a determinant of treatment outcome, making it a target for mechanistic and therapeutic studies.
Inter-individual variation in systemic cholesterol response
In simple terms: People differ in how their blood cholesterol reacts to diet.
Human studies have identified hypo- and hyperresponders who differ in serum cholesterol response to dietary cholesterol and saturated fat. This variation affects the interpretation of dietary fat quality and cardiovascular disease risk, and it underscores the need for mechanistic models that capture individual differences in response to cholesterol.
Key Genes Involved in GO:0070723 response to cholesterol
The following genes and proteins are central to cholesterol sensing, biosynthesis, transport, and downstream signaling within the response to cholesterol process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SREBF1 | Encodes SREBP-1, a transcription factor regulating lipogenic and cholesterol-related genes | Key node in adaptive response to extracellular stress and cholesterol synthesis |
| SREBF2 | Encodes SREBP-2, master regulator of cholesterol biosynthesis and uptake | Central to SREBP-mediated cholesterol response and stress adaptation |
| HMGCR | Rate-limiting enzyme in cholesterol biosynthesis | Target of statins and downstream of SREBP; relevant to cholesterol response |
| LDLR | Mediates uptake of LDL cholesterol | Determines cellular cholesterol availability and feedback regulation |
| ABCA1 | Cholesterol efflux transporter | Affects cellular cholesterol balance and inflammatory signaling |
| ABCG1 | Cholesterol efflux transporter | Modulates macrophage cholesterol and immune responses |
| NR1H2 | Encodes LXR-beta, a nuclear receptor responsive to oxysterols | Links cholesterol metabolites to transcriptional responses |
| NR1H3 | Encodes LXR-alpha, regulator of cholesterol efflux and inflammation | Integrates cholesterol response with innate immunity |
| CYP27A1 | Converts cholesterol to oxysterols and bile acids | Generates signaling metabolites that mediate cholesterol response |
| CYP46A1 | Cholesterol 24-hydroxylase, produces 24S-hydroxycholesterol | Relevant to brain cholesterol turnover and neuronal response |
| SCAP | SREBP cleavage-activating protein, senses sterols | Essential for SREBP processing in response to cholesterol |
| INSIG1 | Retains SREBP in ER when sterols are abundant | Negative regulator of cholesterol synthesis |
| INSIG2 | Similar to INSIG1, regulates SREBP processing | Modulates cholesterol response and lipid homeostasis |
| PCSK9 | Promotes LDL receptor degradation | Affects cholesterol uptake and plasma cholesterol response |
| CETP | Transfers cholesteryl esters between lipoproteins | Influences HDL/LDL response to diet and drugs |
| APOE | Lipoprotein involved in cholesterol transport | Modulates systemic and cellular cholesterol response |
| STING1 | Mediates cytosolic DNA sensing and interferon response | Inhibited by cholesterol biosynthesis in radiotherapy resistance |
| PGR | Progesterone receptor | Attenuated by cholesterol in endometrial cancer progestin resistance |
How Is response to cholesterol Regulated?
The response to cholesterol is regulated at multiple levels. Transcriptional control through SREBP and its regulators SCAP and INSIG proteins adjusts cholesterol synthesis and uptake in response to sterol levels. Nuclear receptors such as LXRs respond to oxysterol metabolites and regulate cholesterol efflux and inflammatory gene programs. In disease contexts, radiotherapy-induced cholesterol biosynthesis can suppress cGAS-STING signaling, providing an example of stress-regulated cholesterol response. Additionally, cholesterol can attenuate progestin signaling in endometrial cancer, indicating cross-talk with hormone receptor pathways. These layers of regulation allow cells to integrate cholesterol availability with stress, immune, and endocrine signals.
response to cholesterol and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PGR | Endometrial cancer progestin resistance | PGR knockout or point-mutation endometrial cancer cell lines treated with cholesterol and progestin |
| STING1 | Colorectal cancer radiotherapy resistance | STING1 knockout or reporter knock-in colorectal cancer cells with cholesterol biosynthesis modulation |
| LDLR | Cardiovascular disease and cholesterol uptake | LDLR knockout or overexpression hepatocyte models for cholesterol response |
| SREBF2 | Cholesterol biosynthesis and stress adaptation | SREBF2 knockout or inducible overexpression cell models under stress |
| ABCA1 | Cholesterol efflux and inflammation | ABCA1 knockout macrophages for inflammatory response to cholesterol |
Cancer therapy resistance
Cholesterol response pathways contribute to resistance to endocrine therapy and radiotherapy. Cholesterol desensitizes endometrial cancer to progestin by attenuating progestin signaling, suggesting that targeting cholesterol response could restore sensitivity. In colorectal cancer, radiotherapy induces cholesterol biosynthesis, which inhibits cGAS-STING activation and contributes to treatment resistance, linking cholesterol metabolism to immune evasion.
Cardiovascular disease and dietary response
Individual variation in serum LDL-cholesterol response to dietary fatty acids and cholesterol has been proposed to explain part of the controversy over fat quality and cardiovascular disease risk. Hypo- and hyperresponders show reproducible differences in serum cholesterol response to diet, which may affect risk stratification and dietary recommendations. Public health debates around eggs, saturated fat, and cholesterol continue, highlighting the need for mechanistic understanding of response to cholesterol.
Inflammation and innate immunity
Cholesterol is a modulator of innate immunity and inflammation. Cholesterol crystals and altered cholesterol trafficking can activate inflammatory pathways, and cholesterol-lowering interventions can change immune cell responses. This has implications for atherosclerosis, autoimmunity, and infections, where response to cholesterol shapes disease progression.
From response to cholesterol-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a gene mediate cholesterol-induced progestin resistance? | PGR knockout or point-mutation endometrial cancer cells |
| Does cholesterol biosynthesis regulate cGAS-STING activation? | STING1 reporter knock-in colorectal cancer cells with cholesterol pathway perturbations |
| How does SREBP respond to cholesterol depletion or loading? | SREBF2 knockout and tagged knock-in cells for imaging and ChIP |
| What is the role of cholesterol efflux in inflammation? | ABCA1/ABCG1 knockout macrophages |
| Can overexpression of a cholesterol response gene alter therapy sensitivity? | Doxycycline-inducible overexpression cell lines |
| Does a genetic variant alter response to dietary cholesterol? | Knock-in of human variants in model cell lines or organoids |
How to Study the response to cholesterol Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify transcriptional response to cholesterol |
| Lipidomics | Cholesterol and lipid species levels | Quantify cholesterol loading/depletion |
| CRISPR knockout | Loss-of-function effects | Test causal role of candidate genes |
| CRISPR knock-in | Tagged or variant protein expression | Study localization and variant effects |
| Overexpression | Gain-of-function effects | Assess sufficiency of a gene in cholesterol response |
| ChIP-seq | Transcription factor binding | Map SREBP or LXR binding sites |
| Reporter assays | Pathway activity | Measure cGAS-STING or progestin signaling |
| Proteomics | Protein abundance and modifications | Identify signaling changes upon cholesterol stimulus |
Transcriptomic profiling
RNA-seq can identify genes whose expression changes upon cholesterol stimulation or depletion, revealing the transcriptional arm of GO:0070723. This approach has been used to study SREBP target genes and stress-responsive cholesterol pathways. In cancer models, RNA-seq can uncover cholesterol-induced programs linked to therapy resistance.
Lipidomics and cholesterol quantification
Mass spectrometry-based lipidomics and enzymatic cholesterol assays measure cellular and membrane cholesterol levels, providing the stimulus context for response studies. These methods help define whether a cell is cholesterol-loaded or depleted and correlate with functional outcomes.
CRISPR functional genomics
CRISPR knockout, point mutation, knock-in, and overexpression screens can causally test genes in the response to cholesterol. For example, knocking out STING1 or PGR can reveal their role in cholesterol-mediated therapy resistance. Library screening can identify modifiers of cholesterol response at scale.
Imaging and reporter assays
Fluorescent cholesterol probes, tagged SREBP, and reporter cell lines allow real-time monitoring of cholesterol trafficking and transcriptional responses. These methods are useful for studying the dynamics of response to cholesterol in live cells.
How CRISPR Can Be Used to Study GO:0070723 response to cholesterol
Knockout
CRISPR knockout of genes such as PGR or STING1 can determine whether they are required for cholesterol-mediated phenotypes, such as progestin resistance or radiotherapy resistance. Knockout models are essential for establishing causality in GO:0070723.
Point Mutation
Point mutations can mimic disease-associated variants or disrupt specific residues in cholesterol response genes, allowing fine mapping of functional domains. This is useful for genes like LDLR or SREBF2 where single amino acid changes affect cholesterol handling.
Knock-in
Knock-in of reporters or tags (e.g., GFP-SREBP2) enables live-cell imaging of cholesterol response dynamics. Knock-in of human variants into model cells can test their impact on response to cholesterol.
Overexpression
Overexpression of cholesterol biosynthesis genes or signaling components can test sufficiency in driving resistance or inflammatory phenotypes. For example, overexpression of cholesterol pathway genes may inhibit cGAS-STING and confer radiotherapy resistance.
How EDITGENE Supports response to cholesterol Research
Researchers studying response to cholesterol-related genes often need to determine whether a candidate gene is causally involved in cholesterol sensing, biosynthesis, or downstream signaling. EDITGENE provides CRISPR-based cell model services to enable such causal studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for response to cholesterol research.
Frequently Asked Questions About response to cholesterol
What is GO:0070723 response to cholesterol?
GO:0070723 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a cholesterol stimulus.
What genes are involved in response to cholesterol?
Key genes include SREBF1, SREBF2, HMGCR, LDLR, ABCA1, ABCG1, NR1H2, NR1H3, SCAP, INSIG1, INSIG2, PCSK9, CETP, APOE, STING1, and PGR.
How does cholesterol affect cancer treatment?
Cholesterol can desensitize endometrial cancer to progestin by attenuating progestin signaling, and radiotherapy-induced cholesterol biosynthesis can inhibit cGAS-STING and cause colorectal cancer treatment resistance.
Why do people respond differently to dietary cholesterol?
Individual variation in serum cholesterol response to diet defines hypo- and hyperresponders, which affects cardiovascular risk interpretation.
What is the role of SREBP in cholesterol response?
SREBP transcription factors regulate de novo cholesterol synthesis and uptake in response to sterol levels and extracellular stress.
How is cholesterol linked to inflammation?
Cholesterol modulates innate immunity and inflammation, with cholesterol crystals and altered trafficking activating inflammatory pathways.
What research methods study response to cholesterol?
RNA-seq, lipidomics, CRISPR knockout/knock-in/overexpression, ChIP-seq, reporter assays, and proteomics are commonly used.
Can CRISPR help study cholesterol response genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in response to cholesterol.
What diseases are associated with response to cholesterol?
Cancer therapy resistance, cardiovascular disease, and inflammatory conditions are associated with altered response to cholesterol.
What is the definition of response to cholesterol in QuickGO?
QuickGO defines GO:0070723 as any process that results in a change in state or activity of a cell or an organism as a result of a cholesterol stimulus.
Conclusion
GO:0070723 (response to cholesterol) is a biologically and clinically important process that integrates cholesterol sensing, transcriptional regulation, immune signaling, and disease outcomes. From SREBP-mediated stress adaptation to cancer therapy resistance and individual dietary responses, the response to cholesterol shapes cell fate and treatment efficacy. CRISPR-based models and functional genomics provide powerful tools to dissect the causal genes and mechanisms underlying this process, supporting both basic discovery and therapeutic development.
References
- 1. Hu J et al.. 2025. Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling.. Sci Transl Med 17(818):eadp0064 PMID: 41032624
- 2. Tall AR et al.. 2015. Cholesterol, inflammation and innate immunity.. Nat Rev Immunol 15(2):104-16 PMID: 25614320
- 3. Griffin BA et al.. 2021. Does variation in serum LDL-cholesterol response to dietary fatty acids help explain the controversy over fat quality and cardiovascular disease risk?. Atherosclerosis 328:108-113 PMID: 33863548
- 4. Zhu L et al.. 2025. Cholesterol biosynthesis induced by radiotherapy inhibits cGAS-STING activation and contributes to colorectal cancer treatment resistance.. Exp Mol Med 57(5):1089-1105 PMID: 40355720
- 5. Antoni R. 2023. Dietary saturated fat and cholesterol: cracking the myths around eggs and cardiovascular disease.. J Nutr Sci 12:e97 PMID: 37706071
- 6. Beynen AC et al.. 1987. Hypo- and hyperresponders: individual differences in the response of serum cholesterol concentration to changes in diet.. Adv Lipid Res 22:115-71 PMID: 3328488
- 7. Robichon C et al.. 2007. De novo cholesterol synthesis at the crossroads of adaptive response to extracellular stress through SREBP.. Biochimie 89(2):260-4 PMID: 17059860
- 8. Cox C et al.. 1995. Individual variation in plasma cholesterol response to dietary saturated fat.. BMJ 311(7015):1260-4 PMID: 7496234
